(0.05%) 5 471.97 points
(0.08%) 39 142 points
(0.35%) 17 779 points
(-0.07%) $80.77
(-3.66%) $2.66
(-0.77%) $2 312.90
(0.25%) $28.94
(3.59%) $1 021.80
(0.29%) $0.936
(0.68%) $10.68
(0.45%) $0.792
(-0.28%) $87.25
Live Chart Being Loaded With Signals
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers...
Stats | |
---|---|
今日成交量 | 0 |
平均成交量 | 1.55M |
市值 | 0.00 |
EPS | $-1.100 ( Q2 | 2022-08-05 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-5.24 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.443 (2.21%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-10-14 | Lesser Brian Andrew | Sell | 42 593 | Common Stock |
2022-10-14 | Lesser Brian Andrew | Sell | 37 500 | Stock Option (Right to Buy) |
2022-10-14 | Potts Jeannette | Sell | 37 500 | Stock Option (Right to Buy) |
2022-10-14 | Potts Jeannette | Sell | 43 958 | Common Stock |
2022-10-14 | Fanucci Marsha | Sell | 7 250 | Common Stock |
INSIDER POWER |
---|
-97.46 |
Last 97 transactions |
Buy: 1 770 820 | Sell: 4 300 300 |
音量 相关性
Forma Therapeutics 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Forma Therapeutics 相关性 - 货币/商品
Forma Therapeutics 财务报表
Annual | 2021 |
营收: | $0.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-4.21 |
FY | 2021 |
营收: | $0.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-4.21 |
FY | 2020 |
营收: | $0.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-3.22 |
FY | 2019 |
营收: | $100.56M |
毛利润: | $0.00 (0.00 %) |
EPS: | $-3.15 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Forma Therapeutics
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobinopathies; and FT-7051 for the treatment of metastatic castration-resistant prostate cancer. The company is also developing Olutasidenib, a selective inhibitor for cancers with isocitrate dehydrogenase 1 gene mutations, which is in Phase II trial for the treatment of relapsed/refractory acute myeloid leukemia and Phase I trial to treat glioma; and FT-8225, a liver-targeted fatty-acid synthase inhibitor designed to block de novo lipogenesis in the liver. Forma Therapeutics Holdings, Inc. was founded in 2007 and is headquartered in Watertown, Massachusetts. As of October 14, 2022, Forma Therapeutics Holdings, Inc. operates as a subsidiary of Novo Nordisk A/S.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。